The Gamma-Aminobutyric Acidergic Effects of Valerian and Valerenic Acid on Rat Brainstem Neuronal Activity

Valerian is a medicinal herb that produces anxiolytic and sedative effects. It was suggested that valerian acts via gamma-aminobutyric acid (GABA)ergic mechanisms. Previous studies showed binding of valerian extract to GABA receptors, but the functional effect of the binding has not been demonstrated. In this study we evaluated the GABAergic effect of valerian extract and one of its major constituents, valerenic acid, on brainstem neuronal activity in an in vitro neonatal rat brainstem preparation. We first observed that muscimol, a GABAA receptor agonist, decreased the firing rate in most brainstem neurons in a concentration-related fashion; 30 &mgr;M produced a 38.9% ± 3.0% (mean ± se) inhibition compared with control values (P < 0.01; 50% inhibitory concentration [IC50], 2.0 ± 0.1 &mgr;M). This effect was antagonized by bicuculline (10 &mgr;M), a GABAA antagonist. Then we showed that valerian extract 3 mg/mL induced a 29.6% ± 5.1% inhibition with an IC50 of 240 ± 18.7 &mgr;g/mL, whereas 100 &mgr;M valerenic acid induced a 22.2% ± 3.4% inhibition with an IC50 of 23 ± 2.6 &mgr;M (both P < 0.01). Bicuculline antagonized the inhibitory effects of both the valerian extract and valerenic acid. In addition, pretreatment with valerian extract or valerenic acid decreased the brainstem inhibitory effects produced by muscimol (both P < 0.05), suggesting that these compounds play an important role in the regulation of GABAergic activity. Data from this study suggest that the pharmacological effects of valerian extract and valerenic acid are mediated through modulation of GABAA receptor function. Thus, valerian may potentiate the sedative effects of anesthetics and other medications that act on GABA receptors, and presurgical valerian use may cause a valerian-anesthetic interaction.

[1]  J T Xie,et al.  Treatment of insomnia: an alternative approach. , 2000, Alternative medicine review : a journal of clinical therapeutic.

[2]  J. Greer,et al.  In vitro brainstem-gastric preparation with intact vagi for study of primary visceral afferent input to dorsal vagal complex in caudal medulla. , 1995, Journal of the autonomic nervous system.

[3]  Josef Hölzl,et al.  Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A(1) adenosine receptors. , 2002, Journal of natural products.

[4]  C. Cavadas,et al.  In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAA receptor in rat brain. , 1995, Arzneimittel-Forschung.

[5]  E. Ernst,et al.  Valerian for insomnia: a systematic review of randomized clinical trials. , 2000, Sleep medicine.

[6]  C. Yuan.  Gastric effects of μ-, δ- and κ-opioid receptor agonists on brainstem unitary responses in the neonatal rat , 1996 .

[7]  P. Doraiswamy,et al.  Cardiac complications and delirium associated with valerian root withdrawal. , 1998, JAMA.

[8]  J. Lipski,et al.  Antidromic activation of neurones as an analytic tool in the study of the central nervous system , 1981, Journal of Neuroscience Methods.

[9]  G. Zetler,et al.  Neuropharmacological Studies on Ethanol Extracts of Valeriana officinalis L.: Behavioural and Anticonvulsant Properties , 1996 .

[10]  T. Suga,et al.  GABA receptor subtypes involved in the neuronal mechanisms of baroreceptor reflex in the nucleus tractus solitarii of rabbits. , 1993, Journal of the autonomic nervous system.

[11]  A. Carvalho,et al.  An aqueous extract of valerian influences the transport of GABA in synaptosomes. , 1994, Planta medica.

[12]  J. Desmeules,et al.  Hepatitis associated with Kava, a herbal remedy for anxiety , 2001, BMJ : British Medical Journal.

[13]  A. Carvalho,et al.  Synaptosomal GABA release as influenced by valerian root extract--involvement of the GABA carrier. , 1994, Archives internationales de pharmacodynamie et de therapie.

[14]  F. Chauffard,et al.  Aqueous Extract of Valerian Reduces Latency to Fall Asleep in Man , 1985, Planta medica.

[15]  S. Russmann,et al.  Kava hepatotoxicity. , 2001, Annals of internal medicine.

[16]  K. Takayama,et al.  Study of possible transmitters in the solitary tract nucleus of the cat involved in the carotid sinus baro- and chemoreceptor reflex. , 1987, Journal of the autonomic nervous system.

[17]  A. Borbély,et al.  Effect of valerian on human sleep , 2004, Psychopharmacology.

[18]  B. Maley,et al.  Immunohistochemical localization of neuropeptides and neurotransmitters in the nucleus solitarius. , 1996, Chemical senses.

[19]  J. Barnes.  Principles and practice of phytotherapy modern herbal medicine , 2001 .

[20]  P J Houghton,et al.  The Scientific Basis for the Reputed Activity of Valerian , 1998, The Journal of pharmacy and pharmacology.

[21]  γ-Aminobutyric Acid Receptor (GABAA) Subunits in Rat Nucleus Tractus Solitarii (NTS) Revealed by Polymerase Chain Reaction (PCR) and Immunohistochemistry , 2001, Molecular and Cellular Neuroscience.

[22]  O. Lindahl,et al.  Double blind study of a Valerian preparation , 1989, Pharmacology Biochemistry and Behavior.

[23]  H. J. Woerdenbag,et al.  Central nervous depressant activity of valerenic Acid in the mouse. , 1985, Planta medica.

[24]  C. Yuan,et al.  Kavalactones and dihydrokavain modulate GABAergic activity in a rat gastric-brainstem preparation. , 2002, Planta medica.

[25]  C. Yuan,et al.  GABAergic effects on nucleus tractus solitarius neurons receiving gastric vagal inputs. , 1998, The Journal of pharmacology and experimental therapeutics.

[26]  J. Müller,et al.  Characterisation of the central nervous depressant activity of a commercially available valerian root extract. , 1993, Arzneimittel-Forschung.

[27]  S. Forman,et al.  Herbal Medicines and Perioperative Care , 2006 .

[28]  J. Medina,et al.  Isolation and identification of 6-methylapigenin, a competitive ligand for the brain GABA(A) receptors, from Valeriana wallichii. , 2002, Planta medica.

[29]  G. Ehrke,et al.  [Inhibition of gamma-aminobutyric acid catabolism by valerenic acid derivatives]. , 1982, Planta medica.

[30]  L. Bonagamba,et al.  Activation of GABA receptors in the NTS of awake rats reduces the gain of baroreflex bradycardia , 2000, Autonomic Neuroscience.

[31]  W. Hening,et al.  Beyond Benzodiazepines: Alternative Pharmacologic Agents for the Treatment of Insomnia , 1998, The Annals of pharmacotherapy.

[32]  G. Johnston.  GABAC receptors. , 1994, Progress in brain research.

[33]  F. Chauffard,et al.  Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man , 1982, Pharmacology Biochemistry and Behavior.